A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
4/21/2026
AcquisitionsDealsNewsletterRetina
Cencora Expands Reach in Retina Care with Acquisition of EyeSouth Partners
Cencora’s agreement to purchase the retinal business of EyeSouth Partners for $1.1 billion is the company’s second major acquisition in an aggressive campaign to become a major, vertically integrat...
4/21/2026
CataractIOLNewsletterOptometryPremium
New OD Survey Looks at Factors Shaping Premium IOL Education Before Referral
Optometrists play an increasingly important role in educating patients about cataract surgery prior to referral, as those patients’ expectations continue to rise. Key findings from Market Scope’s i...
4/21/2026
DeviceEuropeNewsletterRegulation
EU Softens Stance on MDR Transition to Ensure Availability of Needed Devices
Implementation of the European Union’s Medical Device Regulation (MDR) has proven more complex and prolonged than originally anticipated. The new standards took effect in May 2021, ending a four-ye...
4/21/2026
Dry EyeGlaucomaNewsletter
Nanodropper Bottle Tip Adaptor Goes from Simple Idea to Global Product
Mu Medical has been turning heads for years with claims that its Nanodropper bottle tip adaptor cuts typical eye drop volume more than 60 percent, resulting in a single medicine bottle lasting seve...
4/21/2026
AcquisitionsDealsFundingNewsletter
Fundraising Slows in Q1-2026 for Ophthalmic Firms
Market Scope identified 17 ophthalmic deals in Q1-2026, down from 21 in Q1-2025. Fundraising totals reached $856.6 million, a decline from $930.2 million in Q1-2025. The number of deals was below t...
4/21/2026
AcquisitionsDealsNewsletterRetina
Biogen to Acquire Apellis for $5.6 Billion with Eye Toward Growth
Biogen reported March 31 that it had agreed to acquire Apellis Pharmaceuticals, maker of Syfovre, for about $5.6 billion in cash to expand its portfolio of rare-disease medicines. Under the deal, e...
4/21/2026
AcquisitionDealsInstrumentsNewsletter
Halma Acquires Surgistar to Augment MST’s Ophthalmic Instrument Portfolio
UK-based Halma, the parent of ophthalmic instrument maker MicroSurgical Technology (MST) announced April 13 that it had acquired Surgistar, of Vista, California, as an add-on to MST. No financial d...
4/21/2026
CataractDiagnosticIOLNewsletterRetina
Select US FDA Approvals and Clearances in March 2026
The US FDA’s ophthalmic device division granted clearance to three devices using the 510(k) pathway in March 2026, according to the agency’s database. Oculus received clearance for its Pentacam Cor...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.